Genertec Universal Medical Group Company Limited released an announcement on 25 March 2026 detailing the current composition of its Board of Directors and the membership of its five specialized committees. The disclosure serves to formalize governance responsibilities following recent adjustments.
The Board now comprises 11 directors: 1. Executive Directors (3): Chen Shisu (Chairman), Xia Qi (Chief Executive Officer), Wang Lin 2. Non-executive Directors (4): Tong Chaoyin, Lin Chunhai, Huang Youjie, Ma Wanming 3. Independent Non-executive Directors (4): Li Yinquan, Chow Siu Lui, Xu Zhiming, Chan Hiu Fung Nicholas
Committee leadership and membership are as follows: • Audit Committee – chaired by Li Yinquan, with Chow Siu Lui and Tong Chaoyin as members. • Remuneration Committee – chaired by Chow Siu Lui, joined by Lin Chunhai, Huang Youjie, Li Yinquan and Xu Zhiming. • Nomination Committee – chaired by Chen Shisu, with Wang Lin, Li Yinquan, Chow Siu Lui and Chan Hiu Fung Nicholas participating. • Strategy and ESG Committee – chaired by Chen Shisu, accompanied by Huang Youjie and Ma Wanming. • Risk Control Committee – chaired by Ma Wanming, with Xia Qi and Tong Chaoyin serving as members.
The publication underscores Genertec Universal Medical’s commitment to transparent governance by clearly delineating oversight responsibilities across audit, remuneration, nomination, strategic development, environmental-social-governance initiatives, and risk management functions.
Comments